We Study Billionaires - The Investor’s Podcast Network cover image

TIP751: Mastermind Q3, 2025: Uber, Merck, and Bath & Body Works

We Study Billionaires - The Investor’s Podcast Network

00:00

Merck's Oncology Landscape and Future Challenges

This chapter explores Merck's stronghold in the oncology market with its blockbuster drug Keytruda while addressing looming patent expiration and the impact of competitive biosimilars. It also highlights financial challenges regarding drug pricing, inefficiencies caused by middlemen, and Merck’s strategic adaptations in drug delivery methods. The discussion emphasizes the balancing act between current market valuations, investment risk, and future growth potential within the pharmaceutical sector.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app